SDS Optic

SDS Optic Equity

The The Equity of SDS Optic (SDS.WA) as of Oct 24, 2026 is 3.51 M PLN. In the previous year, The Equity was 8.61 M PLN — a change of -59.20% (lower).

Equity

3.51 MPLN

YoY

-59.20%

Last updated:

In 2024, SDS Optic's equity was 3.51 M PLN, a -59.20% increase from the 8.61 M PLN equity in the previous year.

The SDS Optic Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
879,500.00 PLN
Jan 1, 2020
862,200.00 PLN
Jan 1, 2021
9.89 M PLN
Jan 1, 2022
6.41 M PLN
Jan 1, 2023
8.61 M PLN
Jan 1, 2024
3.51 M PLN
The SDS Optic Equity history
YEAREquityYoY
3.51 MPLN-59.20%
8.61 MPLN+34.43%
6.41 MPLN-35.21%
9.89 MPLN+1,046.75%
862,200.00PLN-1.97%
879,500.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SDS Optic Stock analysis

What does SDS Optic do? SDS Optic SA generates revenue by developing biochemistry, engineering, and fiber optic technology solutions specifically designed for cancer diagnosis and treatment. The company focuses its primary research activities on the oncology sector, aiming to improve upon current diagnostic methods that rely on biopsy and histopathology. By implementing the InProbe method, the firm offers a faster and more accurate alternative capable of providing results within 20 minutes to identify cancer markers. The company also conducts research into other diseases, such as fungal diseases, and collaborates with specialists from diverse fields including biology, medicine, technology, and sciences related to medicine. These partnerships support the development of advanced diagnostic tools, positioning the firm to serve the medical and scientific communities seeking improved early detection methods, particularly for breast cancer. SDS Optic is one of the most popular companies on Eulerpool.

Equity Details

Analyzing SDS Optic's Equity

SDS Optic's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding SDS Optic's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating SDS Optic's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

SDS Optic's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in SDS Optic’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about SDS Optic stock

The Equity of SDS Optic is 3.51 M PLN in 2024.

The Equity of SDS Optic changed from 8.61 M PLN to 3.51 M PLN, representing a -59.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity SDS Optic since 2006 – with annual values, charts, and detailed analysis.

The Equity's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's SDS Optic historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SDS Optic

All Key Metrics — SDS Optic